1 Grant
2021
Curve-free phase I/II clinical trial designs for molecularly targeted agents and immunotherapy
Zang, Yong
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA264257-01), $140,044USD, 2021-09-17 -- 2023-08-31